• LAST PRICE
    0.6300
  • TODAY'S CHANGE (%)
    Trending Down-0.0120 (-1.8692%)
  • Bid / Lots
    0.6200/ 153
  • Ask / Lots
    0.6400/ 50
  • Open / Previous Close
    0.6300 / 0.6420
  • Day Range
    Low 0.6200
    High 0.6500
  • 52 Week Range
    Low 0.4115
    High 4.2984
  • Volume
    162,413
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.642
TimeVolumeATHA
09:32 ET138240.6399
09:33 ET1010.6301
09:37 ET13400.631371
09:39 ET3500.6301
09:42 ET79940.639501
09:44 ET11930.6401
09:46 ET10000.641
09:57 ET28530.6311
10:02 ET82120.64
10:06 ET2010.6399
10:11 ET2980.64
10:13 ET3000.6399
10:22 ET36740.631
10:24 ET101000.6374
10:29 ET11500.637
10:33 ET33370.64
10:38 ET20000.6317
10:40 ET2000.635
10:44 ET8560.634921
10:47 ET1000.6316
10:49 ET15890.631
10:54 ET23000.6311
10:56 ET1000.63555
11:00 ET1500.6356
11:05 ET15580.635549
11:07 ET11000.6356
11:12 ET3460.64
11:18 ET5510.631
11:32 ET2000.6355
11:34 ET11500.6311
11:39 ET2250.6399
11:43 ET1000.6311
11:45 ET4460.631
12:03 ET2970.6311
12:06 ET7410.6305
12:12 ET31150.6356
12:14 ET41310.63495
12:17 ET5000.6318
12:19 ET100000.6299
12:21 ET4200.6299
12:24 ET25350.6211
12:30 ET5000.627
12:42 ET210970.62
12:51 ET75000.6207
12:53 ET3990.63
01:02 ET15650.62
01:20 ET16250.6351
01:22 ET10210.6381
01:24 ET2000.63
01:26 ET1000.6296
01:29 ET1000.6345
01:31 ET11300.634246
01:33 ET5000.6223
01:38 ET23140.622
01:40 ET13390.62
01:47 ET20000.63
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesATHA
Athira Pharma Inc
24.7M
-0.2x
---
United StatesCVKD
Cadrenal Therapeutics Inc
24.9M
-2.0x
---
United StatesCLCS
Cell Source Inc
24.9M
-3.2x
---
United StatesABP
ABPRO Holdings Inc
25.0M
20.7x
---
United StatesOCEA
Ocean Biomedical Inc
24.9M
-0.2x
---
United StatesLSTA
Lisata Therapeutics Inc
24.0M
-1.2x
---
As of 2024-11-25

Company Information

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline consists of both blood brain barrier permeable and peripherally restricted drug candidates for the central nervous system (CNS), peripheral nervous system, and other indications. Its lead candidate, fosgonimeton (ATH-1017), is a subcutaneously administered, small molecule positive modulator of the hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) system for CNS disorders. It is also evaluating other drug candidates for the potential treatment of neuropathic pain, amyotrophic lateral sclerosis, Parkinson's disease, and other neurodegenerative diseases. Its ATH-1020 has completed a Phase I single ascending dose evaluation in healthy volunteers. Its ATH-1105 is a small molecule compound designed to be an orally available, once-daily treatment to enhance the HGF/MET system.

Contact Information

Headquarters
18706 North Creek Parkway Suite 104, Box 352141BOTHELL, WA, United States 98011
Phone
425-620-8501
Fax
302-636-5454

Executives

Independent Chairwoman of the Board
Kelly Romano
President, Chief Executive Officer, Director
Mark Litton
Principal Financial Officer and Principal Accounting Officer
Robert Renninger
Chief People Officer
Samantha Willing
Chief Scientific Officer
Kevin Church

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$24.7M
Revenue (TTM)
$0.00
Shares Outstanding
38.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.96
EPS
$-2.85
Book Value
$3.41
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.